| Mrs Leila Marie Lacey, RN | |
|
1039 Islington St, Suite 16, Portsmouth, NH 03801-4262 | |
| (603) 431-0505 | |
| (603) 431-2228 |
| Full Name | Mrs Leila Marie Lacey |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 1039 Islington St, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518394022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 048406-21 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Leila Marie Lacey, RN 1039 Islington St, Suite 16, Portsmouth, NH 03801-4262 Ph: (603) 431-0505 | Mrs Leila Marie Lacey, RN 1039 Islington St, Suite 16, Portsmouth, NH 03801-4262 Ph: (603) 431-0505 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Refusal to File letter in response to the company's New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy which was submitted in May 2011.
Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.
Here is the latest treatment for people with chronic heart failure: a nurse draws blood from the patient, runs that blood through a machine, superheating and "stressing" the blood, and then, injects it back into the patient.
Rigel Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to Fostamatinib, Rigel's oral spleen tyrosine kinase (SYK) inhibitor which is currently in Phase 3 clinical studies in patients with chronic immune thrombocytopenic purpura (ITP).
› Verified 3 days ago
Christine Mckenney, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 377 Leslie Dr, Portsmouth, NH 03801 Phone: 603-944-2582 | |
Dee Perrotta, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 Fax: 603-430-3753 | |
Alison L Ryan, ARNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 121 Corporate Dr Ste 200, Portsmouth, NH 03801 Phone: 603-742-8787 | |
Holly A Hurd, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505 Fax: 603-431-2228 | |
Marjorie Robinson-henry, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 Fax: 603-430-3753 | |
Jane Margaret Reader, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 Fax: 603-430-3753 | |
Mrs. Sarah Marie Crowley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505 Fax: 603-431-2228 |